Search Results
Paolo Ascierto, ASCO 2018 – Personalised strategies and advances in the treatment of melanoma
Paolo A Ascierto, ESMO 2018 – Developments in the treatment of advanced melanoma
Updates in melanoma from ASCO 2018
Dr. Ascierto on Sequencing of Targeted Therapies for Melanoma
Jeffrey S Weber, ASCO 2018 – Resected stage III melanoma and the CheckMate 238 trial
SECOMBIT: sequencing of targeted agents/immunomodulatory Abs in metastatic BRAFV600-mutated melanoma
Dr. Ascierto on the COLUMBUS Trial in Melanoma
Melanoma musings: Dr Ascierto's trial updates from ESMO
Napoli, Ascierto: "Guariamo 50% pazienti con melanoma metastatico, investire in ricerca" (27.05.22)
Dr. Ascierto on Triplet Therapy in BRAF+ Melanoma
Melanoma advancements: immunotherapy in the adjuvant setting
New melanoma treatment leaves 50% of patients cancer free in clinical trial
